Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.7500
-0.0250 (-3.23%)
Sep 29, 2025, 4:35 PM GMT+1
Aptamer Group Revenue
Aptamer Group had revenue of 653.00K GBP in the half year ending December 31, 2024, a decrease of -35.67%. This brings the company's revenue in the last twelve months to 1.22M, up 17.39% year-over-year. In the fiscal year ending June 30, 2024, Aptamer Group had annual revenue of 860.00K, down -50.91%.
Revenue (ttm)
1.22M
Revenue Growth
+17.39%
P/S Ratio
17.20
Revenue / Employee
43.39K
Employees
34
Market Cap
20.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 860.00K | -892.00K | -50.91% |
| Jun 30, 2023 | 1.75M | -2.28M | -56.59% |
| Jun 30, 2022 | 4.04M | 2.76M | 215.31% |
| Jun 30, 2021 | 1.28M | 425.43K | 49.78% |
| Mar 31, 2020 | 854.57K | -132.09K | -13.39% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |
Aptamer Group News
- 4 weeks ago - Aptamer Group launches biomarker discovery service to expand revenue base - The Armchair Trader
- 6 weeks ago - UK Stock Market News: Aptamer, MicroSalt, HICL - The Armchair Trader
- 2 months ago - AIM Market Roundup: Westmount Energy, Aptamer, Europa Oil & Gas - The Armchair Trader
- 7 months ago - Half Year 2025 Aptamer Group PLC Earnings Presentation Transcript - GuruFocus